InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
0
T+90 hit rate
60%
T+90 mean return
+16.0%
Across 5 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the detailed record of transactions filed by Chan Gerald, Director. Officer active across 2 companies, notably Apellis Pharmaceuticals, Inc.. In total, 7 reports have been logged. History available since 1 January 2022. The latest transaction was disclosed on 1 January 2025 (Attribution). Regulator: SEC (Form 4). All data is accessible without signup.
Declarations7 total
25,666 sharesCommon StockSEC:0001193125-26-224606
25,666 sharesCommon StockSEC:0001193125-26-224606:0
6,267 shares0Common StockSEC:0001127602-25-000400:0
3,341 shares0Common StockSEC:0001127602-24-000114:0
3,867 shares0Common StockSEC:0000899243-23-000670:0
4,230 shares0Common StockSEC:0001127602-22-000727
4,230 shares0Common StockSEC:0001127602-22-000727:0
7 of 7 declarations
About Chan Gerald
Chan Gerald is a Board Member at Apellis Pharmaceuticals, Inc. He contributes to the strategy and governance of the company, ensuring that decisions made align with shareholder interests. His expertise in the pharmaceutical sector is an asset for Apellis, fostering innovation and growth.
